InfuSystem Holdings INFU
NYSE INFU
$12.21 +0.01 (+0.08%)
At close: Aug 21, 2026 · 4:00 PM EDT

InfuSystem Holdings (INFU) Cash from Financing Activities (2010 - 2026)

InfuSystem Holdings' (INFU) quarterly Cash from Financing Activities came in at -$790000.0 in Q1 2026, down 142.47% YoY from $1.9 million in Q1 2025, and up 70.77% on a QoQ basis from -$2.7 million in Q4 2025.

InfuSystem Holdings (INFU) Cash from Financing Activities (2010 - 2026) Analysis & Trends

InfuSystem Holdings (INFU) has 17 years of Cash from Financing Activities data on file, last reported at -$790000.0 in Q1 2026.

  • Quarterly Cash from Financing Activities fell 142.47% year-over-year to -$790000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.6 million (down 209.15% YoY) and the FY2025 annual result came in at -$15.0 million, down 116.05% from the prior year.
  • Cash from Financing Activities rose to -$790000.0 in Q1 2026, from -$2.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $3.7 million in Q2 2024 to a low of -$8.0 million in Q3 2025.
  • A 5-year average of -$2.0 million and a median of -$1.7 million in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 4117.35% — and 2024, when it surged 1679.15%.
  • Tracing INFU's Cash from Financing Activities over 5 years: stood at -$1.7 million in 2022, then tumbled by 107.01% to -$3.5 million in 2023, then slipped by 27.4% to -$4.5 million in 2024, then soared by 40.13% to -$2.7 million in 2025, then soared by 70.77% to -$790000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$790000.0 (Q1 2026), -$2.7 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 InfuSystem Holdings 244.87 Mn 243.90 Mn 21.41 Mn -3.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.40 Mn
Jun 30, 2026 -3.40 Mn
Mar 31, 2026 -790,000.00
Mar 31, 2026 -790,000.00
Dec 31, 2025 -2.70 Mn
Dec 31, 2025 -2.70 Mn
Sep 30, 2025 -8.01 Mn
Sep 30, 2025 -8.01 Mn
Jun 30, 2025 -6.11 Mn
Jun 30, 2025 -6.11 Mn
Mar 31, 2025 1.86 Mn
Mar 31, 2025 1.86 Mn
Dec 31, 2024 -4.52 Mn
Dec 31, 2024 -4.52 Mn
Sep 30, 2024 -6.75 Mn
Sep 30, 2024 -6.75 Mn
Jun 30, 2024 3.71 Mn
Jun 30, 2024 3.71 Mn
Mar 31, 2024 632,000.00
Mar 31, 2024 632,000.00